
Philly healthcare and life science investment firm 1315 Capital raises $300M+ for second fund
The investment firm plans to invest $10 million to $30 million in specialty pharma, and medtech companies.
The investment firm plans to invest $10 million to $30 million in specialty pharma, and medtech companies.
It plans to invest in 10 to 14 commercial-stage companies at $10 million to $20 million per business. Last year it co-founded surgical oncology startup Onkos Surgical.